Because tumor-suppressor gene products including BRCA1 and BRCA2 play an important role in telomere maintenance, Dey et al. hypothesized that plasma telomeric cfDNA levels could be associated with the mutation status of BRCA1 and 2 genes. This evidence concerns the gene BRCA1 and neoplasm.